Drug
Carboxyamido-triazole clinical trials
Also written carboxyamidotriazole.
How studies write it
Studies that test it under each name
Other names
- CAI
- 3
Studies by the year they started
7 studies that test it; most in 2000 (3)
| Year | Studies |
|---|---|
| 1994 | 1 |
| 1998 | 2 |
| 1999 | 1 |
| 2000 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 7
National Cancer Institute (NCI) (5) · Eastern Cooperative Oncology Group (1) · National Institutes of Health Clinical Center (CC) (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses carboxyamido-triazole is read from its arms, and is right about nine times in ten.
Testing it · 7
- Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBMCompletedPhase 2National Cancer Institute (NCI)NCT00004146Written as carboxyamidotriazole
- Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung CancerCompletedPhase 3National Cancer Institute (NCI)NCT00003869Written as carboxyamidotriazole
- Carboxyamidotriazole in Treating Patients With Advanced Kidney CancerCompletedPhase 2Eastern Cooperative Oncology GroupNCT00005045Written as carboxyamidotriazole
- Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedPhase 2National Cancer Institute (NCI)NCT00019461Written as carboxyamidotriazole
- Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced CancersCompletedPhase 1National Cancer Institute (NCI)NCT00003249Written as carboxyamidotriazole
- Carboxyamidotriazole in Treating Patients With Metastatic Kidney CancerCompletedPhase 2National Cancer Institute (NCI)NCT00006486Written as carboxyamidotriazole
- Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasCompletedPhase 1National Institutes of Health Clinical Center (CC)NCT00019019Written as carboxyamidotriazole
As the comparator · 1 — what is tested is compared with carboxyamido-triazole
Codes
What other systems call carboxyamido-triazole · ClinicalTrials.gg INT003476
- MeSH (NLM) C062058carboxyamido-triazoleConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 6ST3ZF52WBCARBOXYAMIDOTRIAZOLEConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C062058 | carboxyamido-triazole | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 6ST3ZF52WB | CARBOXYAMIDOTRIAZOLE | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.